AU4641299A - Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin - Google Patents

Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin

Info

Publication number
AU4641299A
AU4641299A AU46412/99A AU4641299A AU4641299A AU 4641299 A AU4641299 A AU 4641299A AU 46412/99 A AU46412/99 A AU 46412/99A AU 4641299 A AU4641299 A AU 4641299A AU 4641299 A AU4641299 A AU 4641299A
Authority
AU
Australia
Prior art keywords
neurotoxin
vaccine
type
clostridium botulinum
immunogenic derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46412/99A
Inventor
Adriaan David Botha
Engela Elizabeth De Bruyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agricultural Research Council
Original Assignee
Agricultural Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Research Council filed Critical Agricultural Research Council
Publication of AU4641299A publication Critical patent/AU4641299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU46412/99A 1998-07-22 1999-07-20 Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin Abandoned AU4641299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA98/6538 1998-07-22
ZA986538 1998-07-22
PCT/IB1999/001301 WO2000005252A1 (en) 1998-07-22 1999-07-20 Vaccine comprising a non-toxic immunogenic derivative of clostridium botulinum type d neurotoxin

Publications (1)

Publication Number Publication Date
AU4641299A true AU4641299A (en) 2000-02-14

Family

ID=25587157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46412/99A Abandoned AU4641299A (en) 1998-07-22 1999-07-20 Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin

Country Status (2)

Country Link
AU (1) AU4641299A (en)
WO (1) WO2000005252A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691983B2 (en) 2000-07-21 2010-04-06 Allergan, Inc. Chimera botulinum toxin type E
US6903187B1 (en) 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
US7491799B2 (en) 2000-07-21 2009-02-17 Allergan, Inc. Modified botulinum neurotoxins
US8445650B2 (en) 2007-09-25 2013-05-21 Thomas Jefferson University Mutant botulinum neurotoxin serotype A polypeptide and uses thereof
JP2021508453A (en) * 2017-12-20 2021-03-11 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ Botulinum toxin cell-binding domain polypeptide and usage for skin rejuvenation
KR20200115584A (en) * 2018-01-30 2020-10-07 칠드런'즈 메디컬 센터 코포레이션 Production of botulinum neurotoxin using the Bacillus system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU627610A1 (en) * 1977-09-30 1980-02-05 Zemlyakova V P V.p.zemlakova's vaccine preparate for clostridyosis control of animals and birds
GB9511909D0 (en) * 1995-06-12 1995-08-09 Microbiological Res Authority Vaccine
GB9617671D0 (en) * 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
AU4245097A (en) * 1996-08-28 1998-03-19 Ophidian Pharmaceuticals, Inc. Multivalent vaccine for (clostridium botulinum) neurotoxin

Also Published As

Publication number Publication date
WO2000005252A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
AU4245097A (en) Multivalent vaccine for (clostridium botulinum) neurotoxin
AU2103797A (en) Clostridium perfringens vaccines
AU2001265043A1 (en) Botulinum toxin implant
AU8875398A (en) 1-amino-7-isoquinoline derivatives as serine protease inhibitors
AU3821497A (en) Methods for isolating nucleic acids using alkaline protease
AU5319299A (en) Soccer headband
AU7245598A (en) Enzyme-mediated modification of fibrin for tissue engineering
AU3992697A (en) Pharmaceutical preparations for intranasal administration
AU5729196A (en) Soluble, active hepatitis c virus protease
AU1951495A (en) Alphavirus rna as carrier for vaccines
AU7690498A (en) Cleavage of fibrin(ogen) and cross-linked fibrin by fibrinolytic matrix metalloproteinases
AU5469801A (en) Pro-liposomal encapsulated preparations (iv)
AU4641299A (en) Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin
AU5128300A (en) Method of operating a boiler
AU7722398A (en) Estimation of active infection by helicobacter pylori
EP1180999A4 (en) Recombinant vaccine against botulinum neurotoxin
AU3187797A (en) Subunit vaccine for (streptococcus equi)
AU2001253181A1 (en) Expression system for efficiently producing clinically effective lysosomal enzymes (glucocerebrosidase)
AU1698699A (en) (helicobacter pylori) vaccine formulations
AU2174497A (en) 6-substituted amino-4-oxa-1-azabicyclo{3,2,0} heptan-7-one deriv atives as cysteine protease inhibitors
AU6454398A (en) Novel rna editing enzyme
AU5290499A (en) Human htra serine protease
AU4450696A (en) Enhanced immunogenic vaccine
AU1849297A (en) Compositions and methods for enzyme deactivation
AU5884798A (en) Sealing section for tunnel segments and tunnel comprising such sealing sections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase